HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.

AbstractBACKGROUND & AIMS:
We previously reported that a high degree of age-related methylation was found in both the dysplastic and nondysplastic mucosa of patients with ulcerative colitis (UC). Whether this translates into hypermethylation in UC-associated cancers (UC-Cs) is not known.
METHODS:
We evaluated the methylation status of 11 genes (MINT1, 2, 31, hMLH1, p16, p14, MGMT, HPP1, SFRP1, ERalpha, and LINE-1) in 48 UC-Cs, 21 UC-associated dysplasias, and 69 sporadic colorectal cancers (S-CRCs) using a quantitative bisulfite pyrosequencing analysis.
RESULTS:
Methylation levels in UC-Cs were lower than S-CRCs for all the genes except MGMT. A methylation index based on the average of Z-scores, for type C (cancer-specific genes: MINT1, MINT2, MINT31, hMLH1, p16, and p14) was -.97 in UC-Cs and .92 in S-CRCs (P = .009). That of type A (age-related genes: HPP1, SFRP1, and ERalpha) was -1.97 in UC-Cs and 1.24 in S-CRCs (P < .001). We observed a significant difference in the incidence of CpG island methylator phenotype between UC-Cs and S-CRCs (8 of 48 [17%] and 26 of 69 [38%]; P = .022). UC-associated dysplasias had significantly higher methylation of type A gene than UC-Cs (Z-score: .07 and -1.97, respectively; P < .001). By contrast, global DNA methylation measured using a LINE-1 assay was significantly higher in UC-Cs than in S-CRCs (58.2% vs 51.0%, P < .001).
CONCLUSIONS:
DNA methylation alterations are uncommon in UC cancers. Given that both genetic and epigenetic changes are common in UC mucosa and dysplasias, we speculate that the genetic changes lead to a more aggressive clinical course than epigenetic changes.
AuthorsKazuo Konishi, Lanlan Shen, Suna Wang, Stephen J Meltzer, Noam Harpaz, Jean-Pierre J Issa
JournalGastroenterology (Gastroenterology) Vol. 132 Issue 4 Pg. 1254-60 (Apr 2007) ISSN: 0016-5085 [Print] United States
PMID17408633 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • APBA1 protein, human
  • APBA2 protein, human
  • Adaptor Proteins, Signal Transducing
  • Cadherins
  • Carrier Proteins
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Estrogen Receptor alpha
  • Intercellular Signaling Peptides and Proteins
  • MLH1 protein, human
  • Membrane Proteins
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • SFRP1 protein, human
  • TMEFF2 protein, human
  • Tumor Suppressor Proteins
  • L1Hs-encoded protein p40, human
  • DNA Modification Methylases
  • MGMT protein, human
  • MutL Protein Homolog 1
  • DNA Repair Enzymes
Topics
  • Adaptor Proteins, Signal Transducing (genetics)
  • Adult
  • Aged
  • Aged, 80 and over
  • Cadherins (genetics)
  • Carrier Proteins (genetics)
  • Colitis, Ulcerative (complications, genetics, metabolism)
  • Colonic Neoplasms (etiology, genetics, metabolism)
  • CpG Islands (genetics)
  • DNA Methylation
  • DNA Modification Methylases (genetics)
  • DNA Repair
  • DNA Repair Enzymes (genetics)
  • DNA, Neoplasm (genetics)
  • DNA-Binding Proteins (genetics)
  • Estrogen Receptor alpha (genetics)
  • Female
  • Follow-Up Studies
  • Friedreich Ataxia
  • Genes, p16 (physiology)
  • Humans
  • Intercellular Signaling Peptides and Proteins (genetics)
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • MutL Protein Homolog 1
  • Neoplasm Proteins
  • Nerve Tissue Proteins (genetics)
  • Nuclear Proteins (genetics)
  • Phenotype
  • Polymerase Chain Reaction
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: